QT Vascular
25 articles about QT Vascular
-
QT Vascular Enters Into Asset Purchase And Option Agreement With Teleflex
5/24/2018
Teleflex will acquire the Company's commercial coronary products and an option to purchase the drug coated Chocolate Heartâ„¢
-
Medtronic Closes $28M Purchase of QT Vascular's Chocolate PTA Balloon Catheter
1/30/2018
Independently, QT Vascular will continue to develop and market its other products including a drug coated version of Chocolate PTA.
-
QT Vascular Begins Enrollment In U.S. Pivotal Study Of Its Drug-Coated Peripheral Balloon
7/31/2017
-
Medtronic Pays $28 Million for QT Vascular's Non-Drug Coated Chocolate PTA
5/12/2017
-
QT Vascular Scores $14.3 Million Capital
3/22/2017
-
QT Vascular Signs Agreement With Medtronic For Distribution Of Chocolate PTA Catheter
2/2/2017
-
FDA Grants QT Vascular Full IDE Approval To Begin Pivotal Trial Of Its Drug-Coated Balloon, Chocolate Touch
12/16/2016
-
QT Vascular Announces That The Federal Circuit Denies AngioScore Petition For Rehearing
11/21/2016
-
QT Vascular Announces FDA Has Granted Approval To Initiate The Pivotal Trial Of Its Novel Drug-Coated Balloon
9/19/2016
-
QT Vascular Announces Federal Circuit Reversal Of Adverse Angioscore / Spectranetics Judgment
7/25/2016
-
QT Vascular Receives CE Mark Clearance For Chocolate Heart, A Novel Drug-Coated Coronary Balloon
7/7/2016
-
QT Vascular Receives FDA 510(k) Clearance For Chocolate XD, A Novel PTCA Balloon
6/27/2016
-
QT Vascular Submits IDE Requesting Permission To Begin Pivotal Trial Of Its Drug-Coated Chocolate Balloon In The United States
4/26/2016
-
QT Vascular Announces Another Positive Outcome In Litigation With Spectranetics/AngioScore, Inc.
2/11/2016
-
QT Vascular Announces Clinical Outcomes Of Its Chocolate Heart Drug Coated Coronary Balloon
1/7/2016
-
QT Vascular Release: Update On AngioScore Litigation
12/1/2015
-
QT Vascular Announces Positive Outcome In Spectranetics/Angioscore Patent Trial
9/30/2015
-
QT Vascular Announces CE Mark Clearance Of Chocolate Touch By LRQA 0088
9/8/2015
-
QT Vascular Obtains Funding To Boost Growth Through Issuance Of Up To US$13.14 Million Convertible Bonds
7/28/2015
-
QT Vascular Announces The Allowance Of Four New Patents
7/15/2015